YICHANG HEC CHANGJIANG PHARMACTL CO revenue for the last year amounted to 6.92 B HKD, the most of which — 6.17 B HKD — came from its highest performing source at the moment, Anti-viral Drugs, the year earlier bringing 3.62 B HKD. The greatest contribution to the revenue figure was made by China — last year it brought YICHANG HEC CHANGJIANG PHARMACTL CO 6.96 B HKD, and the year before that — 4.35 B HKD.